POLI BORTONE ed altri: Disciplina dell'attività di informazione scientifica sui farmaci

This procedure concerns the rules governing how scientific information about pharmaceutical products is communicated. It aims to ensure that the dissemination of medical data is accurate, transparent, and based on scientific evidence to protect public health. This will primarily affect pharmaceutical companies, healthcare professionals, and regulatory bodies responsible for monitoring drug information and marketing practices.